BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

June 15, 2016

Primary Completion Date

June 19, 2018

Study Completion Date

October 30, 2020

Conditions
May-Thurner SyndromePeripheral Vascular DiseaseVenous DiseaseIliofemoral Occlusive Disease
Interventions
DEVICE

VENOVO™ Venous Stent

VENOVO™ Venous stent placement

Trial Locations (21)

2050

Royal Prince Alfred Hospital, Camperdown

6009

JMLS Medical Services PTY LTDT/A PERTH INST. of VASCULAR RESEARCH, Perth

10029

Mount Sinai Medical Center, New York

23542

Sentara Medical Group, Virginia Beach

24501

Centra Health, Inc., dba Stroobants Cardiovascular Center, Lynchburg

25304

CAMC Health Education and Research Institute, Charleston

27607

North Carolina Heart and Vascular, Raleigh

28660

Fundacion de investigacion HM Hospitales, Madrid

49519

Metro Health Hospital, Wyoming

52074

Uniklinik RWTH, Aachen

52803

Midwest Cardiovascular Research Foundation, Davenport

59755

Klinikum Arnberg, Arnsberg

65807

Cox Medical Centers, Springfield

78746

Cardiothoracic and Vascular Surgeons, Austin

79189

Universitaets-Herrzentrum Freiburg-Bad Krozingen, Bad Krozingen

98004

Lake Washington Vascular, PLLC, Bellevue

06820

Vascular Breakthroughs, LLC, Darien

06520

Yale University, New Haven

H91 YR71

University Hospital Galway, Galway

6202 AZ

MUMC Maastricht, Maastricht

SE1 7EH

Guy's & St. Thomas' Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02655887 - BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease | Biotech Hunter | Biotech Hunter